TY - JOUR
T1 - An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation
AU - Porreca, Immacolata
AU - Blassberg, Robert
AU - Harbottle, Jennifer
AU - Joubert, Bronwyn
AU - Mielczarek, Olga
AU - Stombaugh, Jesse
AU - Hemphill, Kevin
AU - Sumner, Jonathan
AU - Pazeraitis, Deividas
AU - Touza, Julia Liz
AU - Francescatto, Margherita
AU - Firth, Mike
AU - Selmi, Tommaso
AU - Collantes, Juan Carlos
AU - Strezoska, Zaklina
AU - Taylor, Benjamin
AU - Jin, Shengkan
AU - Wiggins, Ceri M.
AU - van Brabant Smith, Anja
AU - Lambourne, John J.
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/8/7
Y1 - 2024/8/7
N2 - Gene editing technologies hold promise for enabling the next generation of adoptive cellular therapies. In conventional gene editing platforms that rely on nuclease activity, such as clustered regularly interspaced short palindromic repeats CRISPR-associated protein 9 (CRISPR-Cas9), allow efficient introduction of genetic modifications; however, these modifications occur via the generation of DNA double-strand breaks (DSBs) and can lead to unwanted genomic alterations and genotoxicity. Here, we apply a novel modular RNA aptamer-mediated Pin-point base editing platform to simultaneously introduce multiple gene knockouts and site-specific integration of a transgene in human primary T cells. We demonstrate high editing efficiency and purity at all target sites and significantly reduced frequency of chromosomal translocations compared with the conventional CRISPR-Cas9 system. Site-specific knockin of a chimeric antigen receptor and multiplex gene knockout are achieved within a single intervention and without the requirement for additional sequence-targeting components. The ability to perform complex genome editing efficiently and precisely highlights the potential of the Pin-point platform for application in a range of advanced cell therapies.
AB - Gene editing technologies hold promise for enabling the next generation of adoptive cellular therapies. In conventional gene editing platforms that rely on nuclease activity, such as clustered regularly interspaced short palindromic repeats CRISPR-associated protein 9 (CRISPR-Cas9), allow efficient introduction of genetic modifications; however, these modifications occur via the generation of DNA double-strand breaks (DSBs) and can lead to unwanted genomic alterations and genotoxicity. Here, we apply a novel modular RNA aptamer-mediated Pin-point base editing platform to simultaneously introduce multiple gene knockouts and site-specific integration of a transgene in human primary T cells. We demonstrate high editing efficiency and purity at all target sites and significantly reduced frequency of chromosomal translocations compared with the conventional CRISPR-Cas9 system. Site-specific knockin of a chimeric antigen receptor and multiplex gene knockout are achieved within a single intervention and without the requirement for additional sequence-targeting components. The ability to perform complex genome editing efficiently and precisely highlights the potential of the Pin-point platform for application in a range of advanced cell therapies.
KW - CRISPR
KW - advanced genome editing
KW - allogeneic cell therapy
KW - base editing
KW - gene editing
KW - knockin
KW - knockout
KW - multiple base editing
KW - multiple gene knockout
KW - transgene integration
UR - http://www.scopus.com/inward/record.url?scp=85197795979&partnerID=8YFLogxK
U2 - 10.1016/j.ymthe.2024.06.033
DO - 10.1016/j.ymthe.2024.06.033
M3 - Artículo
C2 - 38937969
AN - SCOPUS:85197795979
SN - 1525-0016
VL - 32
SP - 2692
EP - 2710
JO - Molecular Therapy
JF - Molecular Therapy
IS - 8
ER -